Healthcare Blogs and Articles
Healthcare Blogs and Articles
Healthcare Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Epic quietly announced two network‑based products that extend its electronic health record platform beyond traditional modules like Agent Factory or Penny. The new offerings focus on creating a shared data exchange layer, positioning Epic as a hub for interoperable health information. By leveraging network effects, Epic aims to lock in partners and accelerate feature delivery as development costs shrink with large language model tools. These moves signal a strategic shift toward moat‑building services rather than just core EHR functionality.
Linnea Burman, President of Medtronic Neurovascular, highlighted that nearly 12 million people suffer a stroke each year and one in four die within a year, underscoring persistent global gaps in prevention, access, and long‑term care. She emphasized that rapid treatment is...
Eli Lilly’s Foundayo became the first new molecular entity approved under the FDA’s National Priority Voucher pilot, clearing in a record 50 days. It is the only GLP‑1 weight‑loss pill that can be taken without food or water restrictions, aiming to...
The relentless bombing campaigns in Gaza and southern Lebanon since 2023 have devastated health infrastructure, leaving hospitals overwhelmed and civilian populations without basic medical care. International responders—Médecins Sans Frontières, the International Committee of the Red Cross and its Red Crescent...
Dr. McFillin’s post draws on Solzhenitsyn’s 1974 essay “Live Not By Lies” to argue that the modern mental‑health industry thrives on collective deception. He identifies two core falsehoods: that psychiatric disorders are brain diseases and that DSM diagnoses are medical...
Two March 2026 surveys—Athenahealth’s Physician Sentiment Survey and Gallup’s consumer poll—show health‑care access and affordability now top the concerns of both doctors and the public. Physician worry about affordable care rose to 52 % in 2026, overtaking documentation burdens, while 61 %...
The National Disability Insurance Scheme, a $50 billion Australian program (≈US$33 billion), is acting as a catalyst for employment, especially in health and social assistance sectors. Since 2020, Australian healthcare jobs have diverged from trends in other English‑speaking economies, expanding rapidly. The...
A landmark trial showed blinatumomab adds 10% survival for childhood acute lymphoblastic leukemia, yet most children cannot receive it at home. Roughly 70% lack access to pediatric home‑health services because reimbursement is low, nurses are scarce, and investment has lagged....
In episode 249 of the Xtalks Life Science Podcast, Alex Yang, JD, LLM, CEO of Polaryx, discusses the company’s mission to develop disease‑modifying small‑molecule therapies for rare pediatric lysosomal storage disorders. Yang leverages more than 25 years of experience across...
April 2026 marks IBS Awareness Month, spotlighting a condition that affects roughly 10‑15% of the global population and often goes undiagnosed. The campaign emphasizes education, stigma reduction, and earlier detection to improve quality of life. Meanwhile, the global IBS treatment...
Clinicians’ progress notes are now the primary medical evidence for Veterans Affairs (VA) disability claims, and incomplete documentation is causing a surge in delayed or denied benefits. Last year veterans filed a record number of claims, with roughly one‑third rejected...
US and Israeli airstrikes have demolished more than 115,000 civilian structures across Iran, including over 750 schools, 300 healthcare centers, and 90,000 homes. The attacks have killed over 3,400 people, with at least 1,500 civilians among the dead, and injured...
The U.S. FDA granted accelerated approval to Loargys (pegzilarginase‑nbln) for treating arginase‑1 deficiency (ARG1‑D), an ultrarare metabolic disorder affecting roughly 250 Americans. Loargys, a recombinant human arginase‑1 enzyme, is the first therapy shown to lower plasma arginine levels, achieving about...
Researchers at Tohoku University and City College of New York unveiled a nanotechnology‑based creatinine biosensor that reads concentrations from 1 to 300 mg/dL in about 35 seconds. The device uses a platinum‑nanoparticle polymer composite tuned near the percolation threshold, eliminating the...
The Futurist Global released a post‑conference report on ViVE 2026, drawing insights from 28 top digital‑health leaders. It highlights that physicians access only 3‑5% of patient data, while hospital data volumes are doubling every two years to roughly 50 petabytes per...
The Trump administration has postponed filing an appeal against a federal judge’s injunction on RFK Jr.’s vaccine policy overhaul, citing internal debates over election‑year politics. Meanwhile, Biogen announced a $5.6 billion cash acquisition of Apellis Pharmaceuticals, paying $41 per share—a premium of...
The blog warns that a critical deadline set by Labour leader Keir Starmer is looming over the escalating resident doctors’ strikes in the UK. The British Medical Association (BMA) is pushing for safer staffing ratios and pay increases, while the...
Zai Lab and Amgen have entered a global collaboration to test Zai Lab’s DLL3‑targeting antibody‑drug conjugate, zocilurtatug pelitecan (zoci), together with Amgen’s FDA‑approved bispecific T‑cell engager IMDELLTRA® in extensive‑stage small cell lung cancer (ES‑SCLC). Amgen will sponsor and lead a...
A European Spine Study Group analysis of 310 adult thoracolumbar idiopathic scoliosis patients identified a quality‑of‑life inflection point between ages 30 and 42, after which pre‑operative SRS‑22 scores decline and rarely catch up to younger post‑operative levels. While earlier surgery...
Cyclerion Therapeutics and privately‑held Korsana Biosciences have signed an all‑stock merger agreement, creating a combined company that will operate as Korsana Biosciences and trade on Nasdaq under the ticker KRSA. Korsana secured an oversubscribed $380 million private placement that will fund...
Amprion announced a strategic partnership with Macquarie University to launch Australia’s first clinical alpha‑synuclein seed amplification testing site, expanding its global footprint. The company will continue collaborative research with the Michael J. Fox Foundation in 2026, integrating its SAAmplify‑ɑSYN assay into...
The article argues that high‑stakes medical exams—from the GRE and MCAT to the USMLE and Maintenance of Certification—function primarily as filters for compliance rather than tools for developing clinical reasoning. By presenting closed‑system problems with fixed constants, these tests train...
The April 1, 2026 "Video Wednesday" post serves as a launchpad for a weekly video series that highlights cutting‑edge medical robotics and pandemic‑response technologies. It references earlier "Flickstop" entries that showcased robotic surgery and COVID‑19 disinfection robots, providing visual context for readers....
A recent proof‑of‑concept study introduces DNA‑drug conjugates (DDCs) that turn “smart drugs” into programmable therapies. DDCs use split DNA strands as logic gates to release payloads only when specific biomarker combinations are present, offering higher specificity than antibody‑drug conjugates (ADCs)....
The Amsterdam University Medical Centre, long regarded as the gold standard for paediatric gender medicine, released a retrospective analysis of 1,470 adolescents referred between 2009 and 2019. The study found that 18% of these youths did not pursue gender‑affirming medical...
The biotech sector is witnessing a wave of collaborations and product launches aimed at accelerating drug discovery and expanding genomic knowledge. Biotium introduced the ViaPlex™ 2‑Color Cell Barcoding Kit, enabling multiplex analysis of up to 15 cell populations in a...
Verso Biosense, based in Oxfordshire, is creating a wireless smart IUD that continuously records uterine temperature and oxygen levels. The device aims to generate real‑time data to help clinicians understand why some IVF cycles fail and to identify conditions that...
Seluna’s AI‑driven autoscoring software accurately identified paediatric sleep apnoea in a 500‑patient NHS trial, achieving 100 % sensitivity for severe cases and processing each study in under five minutes. The platform matched human inter‑scorer variability while dramatically cutting analysis time from...
AMSBIO introduced RPMotion, a spinning organoid bioreactor that accelerates and automates 3‑D cell culture for drug discovery, disease modeling and regenerative medicine. The system delivers up to five‑fold faster organoid expansion while cutting reagent costs by roughly 60% and labor...
Boston Scientific announced FDA 510(k) clearance for its Asurys Fluid Management System, a device that provides automated irrigation and intrarenal pressure control during endoscopic urologic procedures such as ureteroscopy. The system integrates with the LithoVue Elite single‑use digital ureteroscope, allowing...
Kevin Wang, chief medical officer of Suki, discussed the evolution of ambient documentation technology that automates clinical note‑taking and now extends into coding and billing assistance. Suki’s AI‑driven platform is sold directly to providers and embedded in partner solutions such...
A new longitudinal study of 83 healthy military personnel tracked cardiac biomarkers after two mRNA COVID‑19 vaccine doses. Within two weeks of the second shot, 49% of participants exhibited a rise in NT‑proBNP exceeding 1.5 times their baseline, indicating subclinical...
Orthopedic surgeons from the American Association of Hip and Knee Surgeons spent a day lobbying in Washington, D.C., highlighting steep Medicare reimbursement cuts and advocating for continued support of alternative payment models (APMs). The group met with congressional staff, testified...
A new animal study suggests that erythritol, a zero‑calorie sugar alcohol popular in low‑carb foods, may promote blood clot formation in the brain, raising concerns about stroke risk. Researchers observed increased cerebral clotting in mice fed typical dietary levels of...
Canadian psychiatrists testified before a parliamentary committee that expanding Medical Assistance in Dying (MAiD) to include mental illness alone is premature. They highlighted unreliable data, inadequate screening for suicide risk, and a surge in Track 2 MAiD use among vulnerable groups....
Persuasive technologies are emerging as essential tools for value‑based health care, turning policy goals into daily patient actions. By providing feedback loops, personalized recommendations, and habit‑forming reminders, they improve medication adherence, chronic disease self‑management, and post‑surgical recovery. Remote monitoring and...
Wireless functionality is now standard in medical devices, but it adds a parallel set of regulatory hurdles across global markets. Manufacturers must secure CE RED, UKCA, FCC, and ISED approvals in addition to traditional device clearances, even when using pre‑certified...
The UK Department of Health and Social Care released a new Pandemic Preparedness Strategy that shifts pandemic planning from a reactive stance to a standing policy priority. It calls for scalable diagnostic capacity, stronger supplier resilience, and expanded strategic stockpiles,...
Elecoglipron (ECC5004/AZD5004), an oral small‑molecule GLP‑1 receptor agonist, completed Phase 2 trials in type 2 diabetes and obesity, meeting primary endpoints in the SOLSTICE and VISTA studies. AstraZeneca licensed global rights from Eccogene for an upfront payment of $185 million and potential milestones...
Cold Chain Technologies (CCT) announced a formal pledge to achieve net‑zero global emissions by 2050, focusing on Scope 3 emissions that represent roughly 80% of a pharmaceutical company’s carbon footprint. The company has already reduced landfill waste by 147 million lb, surpassing its...
ImmunityBio secured $75 million of non‑dilutive financing under its existing royalty‑interest purchase agreement with Oberland Capital, raising total committed capital to $375 million. At the same time, Nant Capital converted $25 million of debt into common stock, reducing the company’s liabilities. The combined...
Republicans in the House are proposing to pull roughly $30 billion from federal health‑care subsidies to fund President Trump’s expanded Middle‑East war and a simultaneous ICE expansion. The plan would strip coverage from an estimated 300,000 Americans, bundling three politically sensitive...
AI Med Consult and 4th Dimension EMR announced a strategic partnership at the AACS Annual Scientific Meeting, integrating AI‑driven patient engagement tools with 4D EMR’s aesthetic‑medicine platform. The combined solution will feed real‑time interaction data into electronic medical records, delivering...
Bristol Myers Squibb announced the evolution of its Standing in the Gaap program, expanding its reach to address equity gaps in multiple myeloma care. The initiative will launch one of the largest U.S. multiple myeloma surveys, targeting more than 1,000...
Artificial intelligence is reshaping clinical development by augmenting, not replacing, human expertise. AI already accelerates medical imaging, compound discovery and COVID‑19 vaccine modeling, compressing timelines from years to months. In clinical outcome assessment (COA) translation, AI can support draft translation...
American medicine is moving from an expansion mindset to confronting permanent resource constraints driven by workforce shortages, supply‑chain fragility, climate impacts, and rising costs. The pandemic stripped away safety buffers, exposing the need for systemic redesign rather than incremental cost‑cutting....
Natera’s Signatera circulating‑tumor DNA test was shown in a prospective Clinical Cancer Research study to identify older women (≥70) with early‑stage ER⁺/HER2‑ breast cancer who can safely forgo surgery and remain progression‑free on primary endocrine therapy. Baseline MRD‑negative patients (68%...
NVIDIA has assembled a comprehensive AI infrastructure stack for healthcare, encompassing BioNeMo, MONAI, Isaac for Healthcare, Holoscan, Parabricks, Clara and NIM. Its 2026 State of AI in Healthcare survey shows 70% of organizations actively using AI, with generative models now...
Pharma executives face accelerating market pressure, prompting a shift from static launch plans to agile, data‑driven execution. Remco op den Kelder of Inizio Ignite argues that real‑time insights, AI integration, and cross‑functional collaboration are essential for successful product launches over...
The article charts the transition of pharmaceutical 3D printing from research pilots to routine pharmacy practice, focusing on pediatric compounding. Companies such as FabRx and CurifyLabs have built platforms that let pharmacists print chewable tablets, gels, and mini‑tablets tailored to...
